Search

"Ultra-short Duration Direct Acting Anti-Viral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients"

Originally aired on Tuesday, January 21, 2020 • Hosted by the Infectious Disease Community of Practice (IDCOP)

"Ultra-short Duration Direct Acting Anti-Viral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients."
(Am J Transplant. 2019 Oct 25. doi: 10.1111/ajt.15664. [Epub ahead of print]).

In this article:
[The authors] conducted an adaptive design single-center pilot trial between October 2017 and November 2018 to determine the safety and efficacy of ultra-short-term perioperative pangenotypic direct acting antiviral (DAA) prophylaxis for deceased hepatitis C virus (HCV)-nucleic acid test (NAT) positive donors to HCV negative kidney recipients (D+/R-).... At a median follow-up of 8 months posttransplant, overall patient and allograft survivals were 98%, respectively. The 4-day strategy reduced viral transmission to 7.5% (3/40; 95% confidence interval [CI]: 1.8%-20.5%) and could result in avoidance of prolonged posttransplant DAA therapy for most D+/R - transplants.

Speakers:
Gaurav Gupta, MD • Virginia Commonwealth University, Richmond, VA
Richard Sterling, MD • Virginia Commonwealth University, Richmond, VA

Moderator:
Deirdre Sawinski, MD, FAST • University of Pennsylvania Hospital, Philadelphia, PA

Watch Video

AST/AJT Journal Club

See all Journal Clubs

Donate

Donate

Donate

to the American Society of Transplantation

Career Center

Career Center

Career Center

Connecting Transplantation Talent with Opportunities

Patient Education

Patient Education

Educating the Community

The AST initiative, Power2Save, has great resources for patients and patient families.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.